USPTO serial 99889749
NAKU
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- MICHOS, LESLIE BISHOP
- Law office
- TMEG LAW OFFICE 107
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with NAKU?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Hoofddorp, NL
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joyce M. Ferraro
Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd Street, 17th FloorNew York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Biological preparations for use in the pharmaceutical industry; biological preparations for scientific and research use; biological cell preparations for use in the pharmaceutical industry and for laboratory and scientific use; T-cells and gamma delta T-cells for use in the pharmaceutical industry and for laboratory and scientific use; cell cultures for use in the pharmaceutical industry and for laboratory and scientific use; biological materials for use in cellular engineering; biological materials for use in immunology research; cellular starting materials for use in the pharmaceutical industry and for laboratory and scientific use; biological preparations for use in the development of cellular therapies; biological materials for use in pharmaceutical and biomedical research | ACTIVE | — |
| 005 | Pharmaceutical and biological preparations for medical and therapeutic use; cellular preparations for medical and therapeutic use; T-cells and gamma delta T-cells for medical and therapeutic use; genetically engineered cellular preparations for medical and therapeutic use; engineered immune cell preparations for medical and therapeutic purposes; biological preparations for use in cellular therapy; cell-based therapeutic preparations; cellular therapeutic preparations for the treatment of cancer, infectious diseases and immune-related disorders | ACTIVE | — |
| 042 | Pharmaceutical and biomedical research and development services; scientific research and development in the field of biotechnology, immunology, cell therapy, immunotherapy and regenerative medicine; scientific research relating to immune cells, T-cells, gamma delta T-cells, adoptive cell therapies and cancer therapies; laboratory research relating to cellular and genetic engineering; development of engineered immune cells and cellular therapeutic products for therapeutic applications; laboratory services relating to biotechnology and cellular manipulation; clinical research services; scientific consultancy relating to biotechnology, immunotherapy and pharmaceutical development; providing scientific information relating to cellular therapies and immunotherapeutics | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2026 | MAB1 | ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT | — |
| Aug 26, 2026 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Aug 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2026 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| Jun 17, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 17, 2026 | NWAP | NEW APPLICATION ENTERED | — |